Phase Ia/II, two-arm, open-label, dose-escalation study of oral panobinostat administered via two dosing schedules in patients with advanced hematologic malignancies

D. J. Deangelo, A. Spencer, K. N. Bhalla, H. M. Prince, T. Fischer, T. Kindler, F. J. Giles, J. W. Scott, K. Parker, A. Liu, M. Woo, P. Atadja, K. K. Mishra, O. G. Ottmann

Research output: Contribution to journalArticlepeer-review

104 Scopus citations

Fingerprint

Dive into the research topics of 'Phase Ia/II, two-arm, open-label, dose-escalation study of oral panobinostat administered via two dosing schedules in patients with advanced hematologic malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences